2005
DOI: 10.1111/j.1365-2249.2005.02838.x
|View full text |Cite
|
Sign up to set email alerts
|

Possible role of autoantibodies against nephrin in an experimental model of chronic graft-versus-host disease

Abstract: SummaryNephrin, a product of the NPHS1 gene, is a component of the slit diaphragms that are found between glomerular foot processes and is a crucial element for glomerular filtration barrier. Recently, nephrin has been focused in a number of studies of proteinuria development including various types of acquired glomerular diseases including minimal change nephrotic syndrome and membranous nephropathy. However, the precise role of nephrin in such acquired glomerular diseases is still unknown. To analyse the rol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 24 publications
0
8
0
Order By: Relevance
“…35 Others demonstrated the development of anti-nephrin autoantibodies and mesangioproliferative glomerulonephritis in a mouse model of chronic graftversus-host disease after non-myeloablative transplantation. 36 Small studies have separately characterized efficacy of the anti-CD20 agent rituximab in treatment of chronic graft-versus-host disease, 37 and idiopathic membranous glomerulonephritis. [38][39][40][41] Thus, it is not unexpected that rituximab-treated hematopoietic cell transplantation recipients with biopsy proven membranous glomerulonephritis responded well (three allogeneic and one autologous transplant).…”
Section: Discussionmentioning
confidence: 99%
“…35 Others demonstrated the development of anti-nephrin autoantibodies and mesangioproliferative glomerulonephritis in a mouse model of chronic graftversus-host disease after non-myeloablative transplantation. 36 Small studies have separately characterized efficacy of the anti-CD20 agent rituximab in treatment of chronic graft-versus-host disease, 37 and idiopathic membranous glomerulonephritis. [38][39][40][41] Thus, it is not unexpected that rituximab-treated hematopoietic cell transplantation recipients with biopsy proven membranous glomerulonephritis responded well (three allogeneic and one autologous transplant).…”
Section: Discussionmentioning
confidence: 99%
“…Podocyte-associated proteins might serve as targets for the circulating alloimmune antibodies that are directed against a podocyte antigen expressed in the recipient but absent from the donor, or against an allovariant. Autoantibodies against nephrin were produced in an experimental model [24] . The possible connection between fetal cell microchimerism (i.e.…”
Section: Alloimmune Nephropathies In the Native Kidney: Do They Occurmentioning
confidence: 99%
“…Antibodies against nephrin, the slit diaphragm protein, have been observed in patients with congenital nephrotic syndrome of the Finnish type who developed recurrent nephrotic syndrome in renal grafts after transplantation. 3 nagahama et al 4 detected anti bodies against nephrin in the sera derived from mouse models of chronic GVHD-which is characterized by a condition similar to systemic lupus erythematosus with severe immune complex glomerulonephritis-before and during proteinuria development. Co-localization of igG and nephrin was seen, which suggested in situ immune complex formation.…”
Section: Discussion Of Diagnosismentioning
confidence: 98%